Yamakawa H, Yokosawa M. Contemporary Guideline Perspectives on Methotrexate and Biologic/Targeted Synthetic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Intern Med 2026 Aug 25. doi: 10.2169/internalmedicine.8144.
PMID: 42649071